TECOGEN Files Routine 8-K for Regulation FD Disclosure
Ticker: TGEN · Form: 8-K · Filed: Jan 16, 2024 · CIK: 1537435
| Field | Detail |
|---|---|
| Company | Tecogen Inc. (TGEN) |
| Form Type | 8-K |
| Filed Date | Jan 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, compliance, 8-K
TL;DR
**TGEN filed a routine 8-K; no new news, just standard compliance.**
AI Summary
TECOGEN INC. (OTCQX: TGEN) filed an 8-K on January 16, 2024, indicating a routine filing under Regulation FD Disclosure and Financial Statements and Exhibits. This filing does not contain new material information but rather serves as a procedural update, confirming the company's adherence to SEC reporting requirements. For investors, this means there's no immediate news impacting the stock, but it reinforces the company's ongoing compliance with regulatory obligations.
Why It Matters
This filing is a standard regulatory update, indicating TECOGEN is maintaining its compliance with SEC rules, which is a positive sign for corporate governance but offers no new financial or operational insights.
Risk Assessment
Risk Level: low — This 8-K is a procedural filing with no new material information, posing no immediate risk to investors.
Analyst Insight
A smart investor would note this as a routine compliance filing, indicating no immediate need for action or re-evaluation of TECOGEN stock based solely on this document. It's a 'no news is good news' scenario for regulatory compliance.
Key Players & Entities
- TECOGEN INC. (company) — the registrant filing the 8-K
- OTCQX: TGEN (company) — the trading symbol for TECOGEN INC.
- January 16, 2024 (date) — date of earliest event reported and filing date
- 001-36103 (dollar_amount) — Commission File Number
- 04-3536131 (dollar_amount) — IRS Employer Identification No.
FAQ
What is the purpose of this specific 8-K filing by TECOGEN INC.?
This 8-K filing by TECOGEN INC. is categorized under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits,' indicating it's a routine update to comply with SEC reporting requirements rather than announcing a specific new event.
What is the earliest event reported date in this 8-K filing?
The earliest event reported date in this 8-K filing is January 16, 2024, which is also the date the report was filed.
Where is TECOGEN INC.'s principal executive office located?
TECOGEN INC.'s principal executive office is located at 45 First Avenue, Waltham, Massachusetts, 02451.
What is TECOGEN INC.'s Commission File Number?
TECOGEN INC.'s Commission File Number, as stated in the filing, is 001-36103.
Does this 8-K indicate TECOGEN INC. is an emerging growth company?
No, the filing indicates with a '☐' that TECOGEN INC. is not an emerging growth company, nor has it elected not to use the extended transition period if it were one.
Filing Stats: 482 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-01-16 16:30:34
Filing Documents
- tgen-20240116.htm (8-K) — 25KB
- investorpresentationfors.htm (EX-99.01) — 15KB
- investorpresentationfors001.jpg (GRAPHIC) — 78KB
- investorpresentationfors002.jpg (GRAPHIC) — 180KB
- investorpresentationfors003.jpg (GRAPHIC) — 111KB
- investorpresentationfors004.jpg (GRAPHIC) — 104KB
- investorpresentationfors005.jpg (GRAPHIC) — 156KB
- investorpresentationfors006.jpg (GRAPHIC) — 73KB
- investorpresentationfors007.jpg (GRAPHIC) — 60KB
- investorpresentationfors008.jpg (GRAPHIC) — 62KB
- investorpresentationfors009.jpg (GRAPHIC) — 81KB
- investorpresentationfors010.jpg (GRAPHIC) — 77KB
- investorpresentationfors011.jpg (GRAPHIC) — 159KB
- investorpresentationfors012.jpg (GRAPHIC) — 105KB
- investorpresentationfors013.jpg (GRAPHIC) — 125KB
- investorpresentationfors014.jpg (GRAPHIC) — 106KB
- investorpresentationfors015.jpg (GRAPHIC) — 65KB
- investorpresentationfors016.jpg (GRAPHIC) — 83KB
- tgen-20240116_g1.jpg (GRAPHIC) — 7KB
- 0001537435-24-000002.txt ( ) — 2414KB
- tgen-20240116.xsd (EX-101.SCH) — 2KB
- tgen-20240116_lab.xml (EX-101.LAB) — 21KB
- tgen-20240116_pre.xml (EX-101.PRE) — 11KB
- tgen-20240116_htm.xml (XML) — 2KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Tecogen Inc. will present the attached slides at a Micro-Cap Conference for investors on January 17 and 18, 2024 hosted by an affiliate of Sidoti & Company, LLC. The slides are being furnished as Exhibit 99.01 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.01 to this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.01 Tecogen Inc. Investor Presentation dated September 17, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. TECOGEN INC. By: /s/ Abinand Rangesh January 16, 2024 Abinand Rangesh, Chief Executive Officer